Clover Health Investments Corp (CLOV)
NASDAQ:CLOV
Want to see CLOV full AI Analyst Report?
CLOV Stock Chart & Stats
$2.19
-$0.09(-2.50%)
At close: 4:00 PM EST
$2.19
-$0.09(-2.50%)
Day’s Range― - ―
52-Week Range$1.58 - $4.23
Previous CloseN/A
Volume2.53M
Average Volume (3M)7.58M
Market Cap
$1.96B
Enterprise Value$1.89B
Total Cash (Recent Filing)$177.56M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Aug 10, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding430,969,400
10 Day Avg. Volume8,562,531
30 Day Avg. Volume7,580,264
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)3.94
Price to Sales (P/S)0.63
P/FCF Ratio-17.62
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue0.85
Enterprise Value/Gross Profit4.65
Enterprise Value/Ebitda-34.22
Forecast
1Y Price Target
$3.20Price Target Upside46.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.04
Revenue Forecast (FY)$2.91B
Bulls Say, Bears Say
Bulls Say
Clinical Technology ImpactWidespread physician adoption of the Clover Assistant is associated with lower medical cost ratios and improved documentation, which can enhance unit economics for members who switch plans.
Membership Growth And RetentionVery high member retention and concentrated growth in Medicare Advantage PPO markets with strong physician engagement supports revenue scale and improves margins as new members stabilize.
Profitability GuidanceGuidance targeting GAAP net income profitability combined with demonstrated ability to absorb large membership inflows without sacrificing profits signals a clearer path to sustainable earnings.
Bears Say
Guidance And Analyst CautionAnalysts maintaining conservative profitability estimates until formal guidance is issued may temper investor expectations and increase stock volatility while visibility remains limited.
Regulatory Rate Notice UncertaintyDisappointing Medicare Advantage rate notices from regulators introduce uncertainty around future margins and complicate forecasting of earnings.
Reimbursement And Star-rating RiskPotential reversion to a lower star payment level and weak Medicare Advantage rate updates could reduce revenue per member and put pressure on profitability.
Clover Health Investments News
CLOV FAQ
What was Clover Health Investments Corp’s price range in the past 12 months?
Clover Health Investments Corp lowest stock price was $1.58 and its highest was $4.23 in the past 12 months.
What is Clover Health Investments Corp’s market cap?
Clover Health Investments Corp’s market cap is $1.96B.
When is Clover Health Investments Corp’s upcoming earnings report date?
Clover Health Investments Corp’s upcoming earnings report date is Aug 10, 2026 which is in 68 days.
How were Clover Health Investments Corp’s earnings last quarter?
Clover Health Investments Corp released its earnings results on May 06, 2026. The company reported $0.073 earnings per share for the quarter, beating the consensus estimate of $0.069 by $0.004.
Is Clover Health Investments Corp overvalued?
According to Wall Street analysts Clover Health Investments Corp’s price is currently Undervalued.
Does Clover Health Investments Corp pay dividends?
Clover Health Investments Corp does not currently pay dividends.
What is Clover Health Investments Corp’s EPS estimate?
Clover Health Investments Corp’s EPS estimate is 0.04.
How many shares outstanding does Clover Health Investments Corp have?
Clover Health Investments Corp has 430,969,400 shares outstanding.
What happened to Clover Health Investments Corp’s price movement after its last earnings report?
Clover Health Investments Corp reported an EPS of $0.073 in its last earnings report, beating expectations of $0.069. Following the earnings report the stock price went up 5.224%.
Which hedge fund is a major shareholder of Clover Health Investments Corp?
Currently, no hedge funds are holding shares in CLOV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Health Investments Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.20 (46.12% Upside)
$3.20 (46.12% Upside)
Blogger Sentiment
Bullish
CLOV Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $954.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.9%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.84%
12-Months-Change
Fundamentals
Return on Equity
-17.08%
Trailing 12-Months
Asset Growth
19.53%
Trailing 12-Months
Company Description
Clover Health Investments Corp
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
CLOV Company Deck
CLOV Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong set of operational and financial positives: rapid membership growth (~51% YoY), significant revenue growth (+62% YoY), improved gross profit (+47% YoY), GAAP profitability ($27M) and expanding clinical engagement (Clover Assistant reach and Clover Care enrollment up ~90%). Management acknowledged elevated outpatient utilization, Part D and prior-period reserve variability and one-time SG&A items, but described concrete actions (AI/data, dental cost controls, targeted remediation) and emphasized disciplined monitoring. Given the magnitude and breadth of the favorable metrics and the balance of challenges being described as manageable or being actively addressed, the overall tone is optimistic and confidence-driven while cautious on cohort maturation risks.View all CLOV earnings summariesCLOV Stock 12 Month Forecast
Average Price Target
$3.20
▲(46.12% Upside)
Technical Analysis
Ownership Overview
6.97% Insiders
7.91% Mutual Funds
0.78% Other Institutional Investors
73.88% Public Companies and Individual Investors